35th week of 2020 patent applcation highlights part 9 |
Patent application number | Title | Published |
20200268690 | TOPICAL COMPOSITIONS | 2020-08-27 |
20200268691 | USE OF METFORMIN AND ANALOGS THEREOF TO REDUCE RAN PROTEIN LEVELS IN THE TREATMENT OF NEUROLOGICAL DISORDERS | 2020-08-27 |
20200268692 | METHODS FOR THE TREATMENT OF CYSTEAMINE SENSITIVE DISORDERS | 2020-08-27 |
20200268693 | METHODS FOR TREATING DISEASES OR INFECTIONS CAUSED BY OR ASSOCIATED WITH H. PYLORI USING A HALOGENATED SALICYLANILIDE | 2020-08-27 |
20200268694 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | 2020-08-27 |
20200268695 | Non-Enzymatic Debriding Agent and Method of Use Thereof | 2020-08-27 |
20200268696 | NON-SURGICAL LASER TREATMENT FOR A FIBROUS MASS | 2020-08-27 |
20200268697 | INHIBITORS OF AUTOPHAGY AND DCAR-1 AS NOVEL ANTHELMINTIC AGENTS | 2020-08-27 |
20200268698 | Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same | 2020-08-27 |
20200268699 | THERAPEUTIC USE OF COMPOUNDS | 2020-08-27 |
20200268700 | COMPOSITIONS AND METHODS FOR INHIBITING BLOOD CANCER CELL GROWTH | 2020-08-27 |
20200268701 | COMPOSITIONS AND METHODS FOR PRODUCING ELEVATED AND SUSTAINED KETOSIS | 2020-08-27 |
20200268702 | METHODS OF TREATING HYPERTRIGLYCERIDEMIA | 2020-08-27 |
20200268703 | MEDICINE FOR TREATING ADVANCED OR RECURRENT CANCER PATIENT BEING NON-RESPONSIVE OR NON-TOLERANT TO STANDARD CHEMOTHERAPY AND INCURABLE AND UNRESECTABLE | 2020-08-27 |
20200268704 | METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR | 2020-08-27 |
20200268705 | CABAZITAXEL COMPOSITION FOR INJECTION AND PREPARATION METHOD THEREFOR | 2020-08-27 |
20200268706 | COMBINATION OF FUROSEMIDE AND STEROIDS AND APPLICATION SYSTEM THEREFOR | 2020-08-27 |
20200268707 | METHODS OF MODULATING PROTEIN EXOCYTOSIS AND USES OF SAME IN THERAPY | 2020-08-27 |
20200268708 | FORMULATION FOR NASAL DELIVERY OF CANNABINOIDS | 2020-08-27 |
20200268709 | SMALL MOLECULES AGAINST CANCER | 2020-08-27 |
20200268710 | METHODS AND COMPOSITIONS INVOLVING BUCINDOLOL FOR THE TREATMENT OF ATRIAL FIBRILLATION | 2020-08-27 |
20200268711 | Use Of Carbamate Compound For Reducing Or Treating Developmental Disorders Including Fragile X Syndrome, Angelman Syndrome Or Rett Syndrome | 2020-08-27 |
20200268712 | EDARAVONE SUSPENSION FOR ORAL ADMINISTRATION | 2020-08-27 |
20200268713 | AUTOTAXIN INHIBITOR COMPOUNDS | 2020-08-27 |
20200268714 | SPIROCYCLIC COMPOUNDS | 2020-08-27 |
20200268715 | DENTAL ANESTHETIC COMPRISING TETRACAINE AND A VASOCONSTRICTOR FOR INTRANASAL ADMINISTRATION | 2020-08-27 |
20200268716 | LULICONAZOLE AS ANTI-ACANTHAMOEBA AGENT AND METHOD FOR PRODUCING THE SAME | 2020-08-27 |
20200268717 | COMPOSITIONS AND METHODS OF REDUCING SERUM CHOLESTEROL AND PCSK9 | 2020-08-27 |
20200268718 | CARBOXAMIDE DERIVATIVES | 2020-08-27 |
20200268719 | ACTIVATOR OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR | 2020-08-27 |
20200268720 | METHODS OF USE OF A CLASS IIA HDAC INHIBITOR | 2020-08-27 |
20200268721 | REGIMEN FOR SUPPRESSING ORGAN REJECTION | 2020-08-27 |
20200268722 | COMPOSITIONS AND METHODS FOR PROMOTING HEMATOPOIETIC STEM CELL REGENERATION | 2020-08-27 |
20200268723 | Therapeutic Uses of Relacorilant, a Heteroaryl-ketone Fused Azadecalin Glucocorticoid Receptor Modulator | 2020-08-27 |
20200268724 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-08-27 |
20200268725 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-08-27 |
20200268726 | METHODS OF TREATMENT OF MALIGNANCIES | 2020-08-27 |
20200268727 | Method of Treating Liver Fibrosis | 2020-08-27 |
20200268728 | DRUG TARGETING CANCER STEM CELL | 2020-08-27 |
20200268729 | NOVEL CXCR4 ANTAGONISTS WITH AMINO ACID SKELETON, PREPARATION THEREFOR AND BIOMEDICAL USE THEREOF | 2020-08-27 |
20200268730 | AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES | 2020-08-27 |
20200268731 | COMPOSITION AND METHODS FOR TREATING HERITABLE PULMONARY ARTERY HYPERTENSION ASSOCIATED WITH NONSENSE MUTATIONS | 2020-08-27 |
20200268732 | Compositions and Methods for Treating Cancer | 2020-08-27 |
20200268733 | METHOD OF TREATING THERMOREGULATORY DYSFUNCTION WITH PAROXETINE | 2020-08-27 |
20200268734 | METHODS OF TREATMENT OF RESPIRATORY DISORDERS | 2020-08-27 |
20200268735 | Combination Therapy of Lasmiditan and a CGRP Antagonist for Use in the Treatment of Migraine | 2020-08-27 |
20200268736 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE | 2020-08-27 |
20200268737 | Liquid Dosage Forms to Treat Cancer | 2020-08-27 |
20200268738 | ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS | 2020-08-27 |
20200268739 | METHODS FOR TREATING IMMUNODEFICIENCY DISEASE | 2020-08-27 |
20200268740 | EZH2 INHIBITOR COMBINATION THERAPIES | 2020-08-27 |
20200268741 | COMPOUNDS AND METHODS FOR INHIBITING NHE-MEDIATED ANTIPORT IN THE TREATMENT OF DISORDERS ASSOCIATED WITH FLUID RETENTION OR SALT OVERLOAD AND GASTROINTESTINAL TRACT DISORDERS | 2020-08-27 |
20200268742 | Combination Therapy for Cancer Treatment | 2020-08-27 |
20200268743 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-08-27 |
20200268744 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-08-27 |
20200268745 | Methods for the Administration of Certain VMAT2 Inhibitors | 2020-08-27 |
20200268746 | Compositions And Kits Useful For Treatment Of Respiratory Illness | 2020-08-27 |
20200268747 | EXTENDED RELEASE, ABUSE DETERRENT DOSAGE FORMS | 2020-08-27 |
20200268748 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | 2020-08-27 |
20200268749 | PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA | 2020-08-27 |
20200268750 | AGENT | 2020-08-27 |
20200268751 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE USING A COMBINATION THERAPY OF SMALL MOLECULE INHIBITORS OF C-C CHEMOKINE RECEPTOR TYPE 9 (CCR9) AND ANTI-ALPHA4BETA7 INTEGRIN BLOCKING ANTIBODIES | 2020-08-27 |
20200268752 | METHODS OF ADMINISTERING ELAGOLIX | 2020-08-27 |
20200268753 | PERK AND IRE-1A INHIBITORS AGAINST NEURODEVELOPMENTAL DISORDERS | 2020-08-27 |
20200268754 | COMPOSITIONS AND METHODS FOR TREATING INSOMNIA | 2020-08-27 |
20200268755 | ALDOSE REDUCTASE INHIBITORS AND USES THEREOF | 2020-08-27 |
20200268756 | DEUTERATED ELAGOLIX-LIKE COMPOSITIONS AND METHODS | 2020-08-27 |
20200268757 | Compounds and Their Use for Reducing Uric Acid Levels | 2020-08-27 |
20200268758 | COMPOSITIONS AND METHODS FOR WHITE TO BEIGE ADIPOGENESIS | 2020-08-27 |
20200268759 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HER-DRIVEN DRUG-RESISTANT CANCERS | 2020-08-27 |
20200268760 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS | 2020-08-27 |
20200268761 | COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING ENHANCED BIOAVAILABILITY | 2020-08-27 |
20200268762 | 7-SUBSTITUTED SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF LIVER CANCER | 2020-08-27 |
20200268763 | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF DRY EYE AND METHODS FOR FABRICATING AND USING THEREOF | 2020-08-27 |
20200268764 | APILIMOD COMPOSITIONS AND METHODS FOR USING SAME | 2020-08-27 |
20200268765 | METHOD OF TREATING MEDULLOBLASTOMA WITH AN EZH2 INHIBITOR | 2020-08-27 |
20200268766 | PHARMACEUTICAL COMPOSITIONS FOR TREATING PAIN | 2020-08-27 |
20200268767 | MEDICAL METHODS UTILISING HIGH PURITY DIAMINOPHENOTHIAZINIUM COMPOUNDS | 2020-08-27 |
20200268768 | CENICRIVIROC COMBINATION THERAPY FOR THE TREATMENT OF FIBROSIS | 2020-08-27 |
20200268769 | METHODS FOR TREATING HELICOBACTER INFECTION | 2020-08-27 |
20200268770 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | 2020-08-27 |
20200268771 | METHOD AND COMPOSITION FOR INHIBITING VIRUS INFECTION | 2020-08-27 |
20200268772 | HIV MATURATION INHIBITOR FORMULATIONS | 2020-08-27 |
20200268773 | COMBINATION OF 25-HYDROXYVITAMIN D AND ANTIOXIDANTS/ANTI-INFLAMMATORIES FOR HUMAN NUTRACEUTICALS | 2020-08-27 |
20200268774 | USE OF PHOSPHORYLATED HEPTOSE COMPOUNDS | 2020-08-27 |
20200268775 | LIPID SUPPLEMENTS FOR REDUCING NERVE ACTION POTENTIALS | 2020-08-27 |
20200268776 | EMULSION COMPOSITION FOR CHEMOEMBOLIZATION AND METHOD FOR PRODUCING SAME | 2020-08-27 |
20200268777 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2020-08-27 |
20200268778 | USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS | 2020-08-27 |
20200268779 | USE OF SECOISOLARICIRESINOL DIGLUCOSIDES (SDGs) AND RELATED COMPOUNDS FOR PROTECTION AGAINST RADIATION-INDUCED CARDIOVASCULAR DYSFUNCTION | 2020-08-27 |
20200268780 | MIXTURE OF INOSITOL DERIVATIVES | 2020-08-27 |
20200268781 | METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | 2020-08-27 |
20200268782 | MULTIVALENT FUCOSE DERIVATIVES FOR USE AS A DRUG | 2020-08-27 |
20200268783 | COMBINATION THERAPY FOR CANCER | 2020-08-27 |
20200268784 | A NUCLEIC ACID MOLECULE WITH ANTI-INFLAMMATORY AND ANTI-COAGULANT AND ORGAN-PROTECTIVE PROPERTIES | 2020-08-27 |
20200268785 | METHOD FOR PREVENTING ORAL CANCER | 2020-08-27 |
20200268786 | RNA CONTAINING COMPOSITIONS AND METHODS OF THEIR USE | 2020-08-27 |
20200268787 | METHODS AND MATERIALS FOR REDUCING AMYLOID BETA LEVELS WITHIN A MAMMAL | 2020-08-27 |
20200268788 | USE OF CYCLODEXTRINS IN DISEASES AND DISORDERS INVOLVING PHOSPHOLIPID DYSREGULATION | 2020-08-27 |
20200268789 | POLYMERIC TREATMENT COMPOSITIONS | 2020-08-27 |